Literature DB >> 14233236

BONE-MARROW HYPOPLASIA FOLLOWING USE OF CHLORAMPHENICOL EYE DROPS.

R L ROSENTHAL, A BLACKMAN.   

Abstract

Entities:  

Keywords:  ANEMIA, APLASTIC; CHLORAMPHENICOL; GENETICS, HUMAN; OPHTHALMIC SOLUTIONS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14233236     DOI： 10.1001/jama.1965.03080020064025

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

Review 1.  Ocular chloramphenicol and aplastic anaemia. Is there a link?

Authors:  S A Rayner; R J Buckley
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

Review 2.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1965-09       Impact factor: 2.401

3.  Detection of chloramphenicol residues in pigs with different agar diffusion methods.

Authors:  H Korkeala; O Mäki-Petäys
Journal:  Acta Vet Scand       Date:  1984       Impact factor: 1.695

4.  Laboratory studies in drug-induced pancytopenia.

Authors: 
Journal:  Br Med J       Date:  1980-02-16

5.  Systemic absorption of topically applied chloramphenicol eyedrops.

Authors:  G E Trope; J R Lawrence; V M Hind; J Bunney
Journal:  Br J Ophthalmol       Date:  1979-10       Impact factor: 4.638

6.  Studies on the influence of leucomycine on the carbohydrate metabolism of the lens in vitro.

Authors:  I Korte; O Hockwin; H Dahlmanns; T Thiemann
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-04-14

7.  Evaluation of amphotericin B and chloramphenicol as alternative drugs for treatment of chytridiomycosis and their impacts on innate skin defenses.

Authors:  Whitney M Holden; Alexander R Ebert; Peter F Canning; Louise A Rollins-Smith
Journal:  Appl Environ Microbiol       Date:  2014-04-25       Impact factor: 4.792

8.  Possible association between ocular chloramphenicol and aplastic anaemia--the absolute risk is very low.

Authors:  J R Laporte; X Vidal; E Ballarín; L Ibáñez
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 9.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

Review 10.  Systemic reactions to ophthalmic drug preparations.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.